Literature DB >> 9499067

Overexpression of C/EBPbeta represses human papillomavirus type 18 upstream regulatory region activity in HeLa cells by interfering with the binding of TATA-binding protein.

T Bauknecht1, Y Shi.   

Abstract

The human papillomavirus type 18 (HPV-18) upstream regulatory region (URR) controls cell type-specific expression of viral oncoproteins E6 and E7. The HPV-18 URR is highly active in HeLa cells, but its activity is virtually undetectable in HepG2 cells. Previous work has shown that YY1 plays an important role in activation of the HPV-18 URR in HeLa cells, and this activating activity is dependent on its physical interaction with C/EBPbeta, which binds to the switch region adjacent to the YY1 site in the URR. Overexpression of C/EBPbeta in HepG2 cells restores C/EBPbeta-YY1 interaction, resulting in strong activation of the HPV-18 URR activity. In this report, we show that, in contrast to the effect in HepG2 cells, overexpression of C/EBPbeta represses the HPV-18 URR in HeLa cells. This C/EBPbeta-induced repression of the HPV-18 URR in HeLa cells is binding site independent. It is also promoter specific, since it activates the albumin promoter under conditions in which it represses the URR in the same cells. Biochemical analysis shows that overexpression of C/EBPbeta in HeLa cells specifically interferes with binding of TATA-binding protein to the TATA box of the HPV-18 URR, but its overexpression in HepG2 cells leads to activation of the HPV-18 URR. These results suggest that a molecular mechanism underlies the ability of C/EBPbeta to regulate transcription in a cell type-specific manner and indicate the potential of using C/EBPbeta to manipulate the activity of the HPV-18 URR in cervical carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9499067      PMCID: PMC109506          DOI: 10.1128/JVI.72.3.2113-2124.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  97 in total

1.  Ig/EBP-1: a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP.

Authors:  C Roman; J S Platero; J Shuman; K Calame
Journal:  Genes Dev       Date:  1990-08       Impact factor: 11.361

2.  Dimerization specificity of the leucine zipper-containing bZIP motif on DNA binding: prediction and rational design.

Authors:  C R Vinson; T Hai; S M Boyd
Journal:  Genes Dev       Date:  1993-06       Impact factor: 11.361

3.  LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein.

Authors:  P Descombes; M Chojkier; S Lichtsteiner; E Falvey; U Schibler
Journal:  Genes Dev       Date:  1990-09       Impact factor: 11.361

4.  IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP.

Authors:  V Poli; F P Mancini; R Cortese
Journal:  Cell       Date:  1990-11-02       Impact factor: 41.582

5.  The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element.

Authors:  B Gloss; H U Bernard
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

6.  Association of human papillomavirus types 16 and 18 E6 proteins with p53.

Authors:  B A Werness; A J Levine; P M Howley
Journal:  Science       Date:  1990-04-06       Impact factor: 47.728

7.  A member of the activator protein 1 family found in keratinocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter.

Authors:  E A Offord; P Beard
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

8.  Molecular cloning of a transcription factor, AGP/EBP, that belongs to members of the C/EBP family.

Authors:  C J Chang; T T Chen; H Y Lei; D S Chen; S C Lee
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

9.  A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.

Authors:  S Akira; H Isshiki; T Sugita; O Tanabe; S Kinoshita; Y Nishio; T Nakajima; T Hirano; T Kishimoto
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

10.  Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.

Authors:  K Münger; B A Werness; N Dyson; W C Phelps; E Harlow; P M Howley
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  11 in total

1.  Cellular transcription factor YY1 mediates the varicella-zoster virus (VZV) IE62 transcriptional activation.

Authors:  Mohamed I Khalil; Marvin Sommer; Ann Arvin; John Hay; William T Ruyechan
Journal:  Virology       Date:  2013-12-12       Impact factor: 3.616

2.  Silencing of integrated human papillomavirus type 18 oncogene transcription in cells expressing SerpinB2.

Authors:  Grant A Darnell; Toni M Antalis; Barbara R Rose; Andreas Suhrbier
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein.

Authors:  K W Vance; M S Campo; I M Morgan
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Trichostatin A up-regulates human papillomavirus type 11 upstream regulatory region-E6 promoter activity in undifferentiated primary human keratinocytes.

Authors:  W Zhao; F Noya; W Y Chen; T M Townes; L T Chow; T R Broker
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

5.  Adeno-associated virus major Rep78 protein disrupts binding of TATA-binding protein to the p97 promoter of human papillomavirus type 16.

Authors:  P F Su; S Y Chiang; C W Wu; F Y Wu
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  YY1 is a novel potential therapeutic target for the treatment of HPV infection-induced cervical cancer by arsenic trioxide.

Authors:  Guifen He; Qian Wang; Yuqi Zhou; Xiaohua Wu; Lan Wang; Nadire Duru; Xiangtao Kong; Pingzhao Zhang; Bo Wan; Long Sui; Qisang Guo; Jian-Jian Li; Long Yu
Journal:  Int J Gynecol Cancer       Date:  2011-08       Impact factor: 3.437

7.  Site-directed mutagenesis of human papillomavirus 18 promoter elements and tissue-specific expression in cervical carcinoma cells.

Authors:  Mandy S Y Lung; Ning Zhang; Vincent Murray
Journal:  Virus Genes       Date:  2012-02-21       Impact factor: 2.332

8.  Transcriptional regulation of mouse mast cell protease-2 by interleukin-15.

Authors:  Farhad Mirghomizadeh; Jörn Bullwinkel; Zane Orinska; Ottmar Janssen; Arnd Petersen; Prim B Singh; Silvia Bulfone-Paus
Journal:  J Biol Chem       Date:  2009-10-01       Impact factor: 5.157

Review 9.  Host cell restriction factors that limit transcription and replication of human papillomavirus.

Authors:  Samuel S Porter; Wesley H Stepp; James D Stamos; Alison A McBride
Journal:  Virus Res       Date:  2016-11-15       Impact factor: 3.303

10.  Transcriptional correlates of disease outcome in anticoagulant-treated non-human primates infected with ebolavirus.

Authors:  Sara Garamszegi; Judy Y Yen; Anna N Honko; Joan B Geisbert; Kathleen H Rubins; Thomas W Geisbert; Yu Xia; Lisa E Hensley; John H Connor
Journal:  PLoS Negl Trop Dis       Date:  2014-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.